Silvia Dellapasqua

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 565 citations

Medicine, Oncology, Surgery +17

Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes

Oreste ­Gentilini, Edoardo Botteri, Claudia Sangalli et al. · JAMA Oncology · 2023 · 498 citations · Full text

Medicine, Oncology, Surgery +16

Metronomic Cyclophosphamide and Capecitabine Combined With Bevacizumab in Advanced Breast Cancer

Silvia Dellapasqua, Francesco Bertolini, Vincenzo Bagnardi et al. · Journal of Clinical Oncology · 2008 · 293 citations

Medicine, Oncology, Pharmacology +15

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes

Patrick Maisonneuve, Davide Disalvatore, Nicole Rotmensz et al. · Breast Cancer Research · 2014 · 201 citations · Full text

Medicine, Oncology, Pathology +15

Invasive lobular breast cancer: subtypes and outcome

Monica Iorfida, Eugenio Maiorano, Enrico Orvieto et al. · Breast Cancer Research and Treatment · 2012 · 171 citations

Medicine, Oncology, Surgery +12